Osaic Holdings
ANIK icon

Osaic Holdings’s Anika Therapeutics ANIK Stock Holding History

Osaic Holdings’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Buy
+100
New +$1.48K ﹤0.01% 7369
2026
Q1 		– Sell
-100
Closed -$961 – 7812
2025
Q4 		$961 Sell
100
-10
-9% -$96 ﹤0.01% 7286
2025
Q3 		$1.01K Hold
110
– – ﹤0.01% 7349
2025
Q2 		$1.16K Buy
110
+100
+1,000% +$1.26K ﹤0.01% 7106
2025
Q1 		$150 Hold
10
– – ﹤0.01% 7201
2024
Q4 		$164 Hold
10
– – ﹤0.01% 7186
2024
Q3 		$247 Hold
10
– – ﹤0.01% 7143
2024
Q2 		$253 Hold
10
– – ﹤0.01% 7132
2024
Q1 		$254 Sell
10
-56,853
-100% -$1.38M ﹤0.01% 6937
2023
Q4 		$1.29M Sell
56,863
-1,662
-3% -$34.4K ﹤0.01% 2254
2023
Q3 		$1.09M Buy
58,525
+58,490
+167,114% +$1.21M ﹤0.01% 2561
2023
Q2 		$907 Sell
35
-38
-52% -$1.02K ﹤0.01% 6905
2023
Q1 		$2.1K Buy
73
+2
+3% +$60 ﹤0.01% 6694
2022
Q4 		$2K Sell
71
-7,482
-99% -$213K ﹤0.01% 6608
2022
Q3 		$180K Buy
7,553
+1,767
+31% +$40.7K ﹤0.01% 3850
2022
Q2 		$129K Buy
5,786
+3,828
+196% +$85.4K ﹤0.01% 4191
2022
Q1 		$49K Buy
1,958
+148
+8% +$4.51K ﹤0.01% 5098
2021
Q4 		$64K Buy
1,810
+158
+10% +$6.32K ﹤0.01% 4947
2021
Q3 		$69K Buy
1,652
+1,038
+169% +$42.8K ﹤0.01% 4847
2021
Q2 		$26K Buy
614
+576
+1,516% +$24.5K ﹤0.01% 5485
2021
Q1 		$1K Sell
38
-1,512
-98% -$57.4K ﹤0.01% 6605
2020
Q4 		$69K Buy
1,550
+1,180
+319% +$44.8K ﹤0.01% 4320
2020
Q3 		$13K Buy
370
+14
+4% +$506 ﹤0.01% 5136
2020
Q2 		$13K Sell
356
-130
-27% -$4.28K ﹤0.01% 5026
2020
Q1 		$15K Buy
+486
New +$19.7K ﹤0.01% 4784

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Osaic Holdings's ANIK Position: Q2 2026 in Review

Osaic Holdings opened a new position in Anika Therapeutics (ANIK) in Q2 2026: 100 shares worth $1.46K. The stake represents ﹤0.01% of the portfolio and ranks #7369 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in ANIK as recently as Q4 2025.

Osaic Holdings first reported a position in ANIK in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.29M in Q4 2023. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Osaic Holdings held 100 shares of Anika Therapeutics worth $1.46K as of Q2 2026.
  • Anika Therapeutics was a new Osaic Holdings position in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7369 holding.
  • Osaic Holdings first reported a position in Anika Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Anika Therapeutics position peaked at $1.29M in Q4 2023.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.